No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
PFE241227P17000
- 0.01
- 0.000.00%
15min DelayTrading Dec 20 10:32 ET
0.00High0.00Low
0.00Open0.01Pre Close0 Volume707 Open Interest17.00Strike Price0.00Turnover167.32%IV35.34%PremiumDec 27, 2024Expiry Date0.00Intrinsic Value100Multiplier4DDays to Expiry0.01Extrinsic Value100Contract SizeAmericanOptions Type-0.0062Delta0.0037Gamma2627.50Leverage Ratio-0.0071Theta0.0000Rho-16.23Eff Leverage0.0005Vega
Intraday
- 5D
- Daily
News
Pfizer's Colorectal Cancer Combo Therapy Gains Accelerated Approval From FDA
TD Cowen Maintains Pfizer(PFE.US) With Hold Rating, Maintains Target Price $32
SA Asks: Which Big Pharmas Are Likely to Announce Big M&A Deals?
Why Pfizer Inc. (PFE) Is One of the Best Stocks to Buy and Hold for 3 Years?
Pfizer Just Reassured Investors, but Is the Stock a Buy?
Pfizer Inc. (PFE) Is Among the Best Dividend Leaders to Buy According to Wall Street Analysts